Agenus (AGEN) Change in Intangibles (2026)
Agenus' (AGEN) quarterly Change in Intangibles came in at $63.9 million in Q1 2026.
Agenus (AGEN) Change in Intangibles (2026) Analysis & Trends
Agenus' Change in Intangibles history runs 1 years deep, the most recent figure standing at $63.9 million for Q1 2026.
- On a quarterly basis, Change in Intangibles changed N/A year-over-year to $63.9 million in Q1 2026; TTM through Mar 2026 was $63.9 million, a N/A change from a year earlier, with the FY2009 full-year figure at $2.3 million, changed N/A from the prior year.
- Change in Intangibles steadied at $63.9 million in Q1 2026 per AGEN's latest filing.
- Across five years, Change in Intangibles topped out at $63.9 million in Q1 2026 and bottomed at $63.9 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Agenus | 234.10 Mn | 199.10 Mn | 33.74 Mn | 63.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.92 Mn |
| Mar 31, 2026 | 63.92 Mn |